why choose us

First received: January 29, 2023

Clinical Trial: Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Effects of Low-dose Dexmedetomidine-esketamine Combined Nasal Administration at Night on Perioperative Sleep Quality in Breast Cancer Patients: a Randomized, Double-blind, Placebo-controlled Trial

Brief Summary: Breast cancer patients often have sleep disturbances during the perioperative period.Dexmedetomidine is a highly selective alpha 2-adrenoceptor agonist with sedative, anxiolytic, and analgesic effects.Previous studies showed that night-time low-dose dexmedetomidine infusion improved sleep quality.Esketamine is a N-methyl-D-aspartic acid receptor antagonist and has been used as an anesthetic and analgesic.Recent studies showed that low-dose esketamine has anti-depressive and sleep-promoting effects.The…

Read more